...
首页> 外文期刊>BMC Genomics >Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation
【24h】

Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation

机译:人骨髓间充质干细胞扩增和成骨细胞分化过程中的基因表达谱

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Human mesenchymal stem cells (MSC) with the capacity to differentiate into osteoblasts provide potential for the development of novel treatment strategies, such as improved healing of large bone defects. However, their low frequency in bone marrow necessitate ex vivo expansion for further clinical application. In this study we asked if MSC are developing in an aberrant or unwanted way during ex vivo long-term cultivation and if artificial cultivation conditions exert any influence on their stem cell maintenance. To address this question we first developed human oligonucleotide microarrays with 30.000 elements and then performed large-scale expression profiling of long-term expanded MSC and MSC during differentiation into osteoblasts. Results The results showed that MSC did not alter their osteogenic differentiation capacity, surface marker profile, and the expression profiles of MSC during expansion. Microarray analysis of MSC during osteogenic differentiation identified three candidate genes for further examination and functional analysis: ID4, CRYAB, and SORT1. Additionally, we were able to reconstruct the three developmental phases during osteoblast differentiation: proliferation, matrix maturation, and mineralization, and illustrate the activation of the SMAD signaling pathways by TGF-β2 and BMPs. Conclusion With a variety of assays we could show that MSC represent a cell population which can be expanded for therapeutic applications.
机译:背景技术具有分化为成骨细胞能力的人间充质干细胞(MSC)为开发新型治疗策略(如改善大骨缺损的愈合)提供了潜力。然而,它们在骨髓中的低频率需要离体扩增以用于进一步的临床应用。在这项研究中,我们询问了MSC在离体长期培养过程中是否以异常或不需要的方式发育,以及人工培养条件是否对其干细胞的维持产生任何影响。为了解决这个问题,我们首先开发了具有30.000个元件的人类寡核苷酸微阵列,然后在分化为成骨细胞的过程中对长期扩增的MSC和MSC进行了大规模表达谱分析。结果结果表明,在扩增过程中,MSC没有改变其成骨分化能力,表面标志物谱和表达谱。在成骨分化过程中对MSC进行的微阵列分析确定了三个候选基因供进一步检查和功能分析:ID4,CRYAB和SORT1。此外,我们能够重建成骨细胞分化过程中的三个发育阶段:增殖,基质成熟和矿化,并说明TGF-β2和BMP对SMAD信号通路的激活。结论通过各种分析,我们可以证明MSC代表了可以扩展用于治疗应用的细胞群。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号